This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
Acerus Pharmaceuticals 配当金
配当金 基準チェック /06
主要情報
n/a
配当利回り
n/a
配当性向
| 業界平均利回り | 2.2% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 一株当たり利益 | -CA$3.64 |
| 3年後の配当利回り予想 | n/a |
最近の配当金アップデート
更新なし
Recent updates
Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)
Mar 14
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?
Mar 12Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares
Jan 22The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares
Nov 30
決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if ASP's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if ASP's dividend payments have been increasing.
配当利回り対市場
| Acerus Pharmaceuticals 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (ASP) | n/a |
| 市場下位25% (CA) | 1.8% |
| 市場トップ25% (CA) | 6.5% |
| 業界平均 (Pharmaceuticals) | 2.2% |
| 3年後のアナリスト予想 (ASP) | n/a |
注目すべき配当: Unable to evaluate ASP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate ASP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as ASP has not reported any payouts.